8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report  (Date of earliest event reported) July 11, 2008

ARES CAPITAL CORPORATION

(Exact Name of Registrant as Specified in Charter)

Maryland	000-50697	33-1089684
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
280 Park Avenue, 22nd Floor, Building East, New York, NY 10017
(Address of Principal Executive Offices)                               (Zip Code)

Registrant’s telephone number, including area code (212) 750-7300

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01  Regulation FD Disclosure

On July 11, 2008, the Registrant issued two press releases, filed herewith as Exhibits 99.1 and 99.2 and incorporated by reference herein.

The information disclosed under this Item 7.01, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

Item 9.01  Financial Statements and Exhibits.

(d)           Exhibits:

Exhibit Number	Description
99.1	Press Release, dated July 11, 2008
99.2	Press Release, dated July 11, 2008

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ARES CAPITAL CORPORATION
Date:   July 11, 2008
	By:	/s/ Richard S. Davis
	Name:	Richard S. Davis
	Title:	Chief Financial Officer

3

Exhibit Index

Exhibit Number	Description
99.1	Press Release, dated July 11, 2008
99.2	Press Release, dated July 11, 2008

4

EX-99.1

Exhibit 99.1

ARES CAPITAL CORPORATION SCHEDULES EARNINGS RELEASE FOR
THE QUARTER ENDED JUNE 30, 2008

NEW YORK, NY — Ares Capital Corporation (NASDAQ: ARCC) announced today that it will report earnings for the quarter ended June 30, 2008 on Thursday, August 7, 2008.

Ares Capital Corporation invites all interested persons to attend its webcast/conference call at 10:00 a.m. (Eastern Time) on Thursday, August 7, 2008 to discuss its second quarter 2008 financial results.

All interested persons are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Stock Information page of the Investor Resources section of our website at www.arescapitalcorp.com. Please visit the website to test your connection before the call. You can also access the conference call by dialing (800) 860-2442 approximately 5-10 minutes prior to the call. International callers should dial (412) 858-4600. All callers should reference “Ares Capital Corporation.” For the convenience of our stockholders, an archived replay of the call will be available through August 22, 2008 by calling (877) 344-7529. International callers please dial (412) 317-0088. For all replays, please reference passcode #421147. An archived replay will also be available on a webcast page located in the Stock Information section of the Investor Resources section of our website.

ABOUT ARES CAPITAL CORPORATION

Ares Capital Corporation is a specialty finance company that is a closed-end, non-diversified management investment company regulated as a business development company under the Investment Company Act of 1940. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. Ares Capital Corporation invests primarily in first and second lien senior loans and mezzanine debt, which in some cases includes an equity component, and, to a lesser extent, in equity investments in private U.S. middle market companies.

FORWARD-LOOKING STATEMENTS

Statements included herein or on the webcast/conference call may constitute “forward-looking statements,” which relate to future events on our future performance or financial condition.  These statements are not guarantees of future performance or results and involve a number of risks and uncertainties.  Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission.  Ares Capital undertakes no duty to update any forward-looking statements made herein or on the webcast/conference call.

AVAILABLE INFORMATION

Ares Capital Corporation’s filings with the Securities and Exchange Commission, press releases, earnings releases and other financial information are available on its website at www.arescapitalcorp.com.

CONTACT

Richard Davis
Ares Capital Corporation
310-201-4200

EX-99.2

Exhibit 99.2

ARES CAPITAL CORPORATION ARRANGES $100.0 MILLION TERM LOAN FACILITY
FOR VANTAGE ONCOLOGY, INC.

NEW YORK, NY — Ares Capital Corporation (NASDAQ: ARCC) is pleased to announce the closing of a $100.0 million Term Loan Facility for Vantage Oncology, Inc. (“Vantage”).  Ares Capital Corporation acted as the Lead Arranger for the facility, which is structured as a delayed draw term loan to support future acquisitions.

“ARCC has been a great partner, providing us with flexible capital to support our growth plans,” said Mike Fiore, Vantage’s CEO.  “We look forward to working closely with ARCC as we further expand our rapidly growing business.”

The investment in Vantage is part of the $342.3 million of investments that ARCC made during the quarter ended June 30, 2008 (including agreements to fund revolving credit facilities or delayed draw loans).  Additionally, ARCC exited $43.4 million of investments during the quarter ended June 30, 2008.

ABOUT VANTAGE

Vantage Oncology, Inc., headquartered in Manhattan Beach, CA, acquires, joint ventures, develops and operates radiation oncology centers of excellence.  The Company has developed a geographically diverse set of centers and now operates in 10 regions which include the Santa Clarita and San Fernando Valleys in Southern California; the Inland Empire in Southern California; Central Texas; Chicago, Illinois; Evansville, Indiana; Cincinnati, Ohio; New York City; Eastern Pennsylvania; Central Florida; and Southern New England (Boston and Providence). The Company’s 31 centers currently provide over 200,000 patient treatments annually, including conventional, IMRT, IGRT, SRS and brachytherapy treatments. Vantage also provides medical physics services to its own centers as well as independent hospital and physician clients through its subsidiary, Vantage Oncology Physics, and provides billing services through its subsidiary, Vantage Medical Management Services. Vantage’s equity investors include: New Enterprise Associates (NEA), CCP Equity Partners, Versant Ventures, Salix Ventures and Camden Partners.

 ABOUT ARES CAPITAL CORPORATION

Ares Capital Corporation is a specialty finance company that is a closed-end, non-diversified management investment company.  Ares Capital Corporation has elected to be regulated as a business development company under the Investment Company Act of 1940. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. Ares Capital Corporation invests primarily in first and second lien senior loans and mezzanine debt, which in some cases includes an equity component, and, to a lesser extent, in equity investments in private U.S. middle market companies.

FORWARD-LOOKING STATEMENTS

Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Ares Capital Corporation’s filings with the Securities and Exchange Commission. Ares Capital Corporation undertakes no duty to update any forward-looking statements made herein.

AVAILABLE INFORMATION

Ares Capital Corporation’s filings with the Securities and Exchange Commission, press releases, earnings releases and other financial information are available on its website at www.arescapitalcorp.com.

CONTACT

Investor Relations

Rick Davis

Ares Capital Corporation

310-201-4200